Picture of Valerio Therapeutics SA logo

ALVIO — Valerio Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Onxeo H1 Current Operating Loss Widens To 6.9 Million Euros

July 26 (Reuters) - ONXEO SA  C4X.PA :
    * REPORTED ON THURSDAY H1 NET LOSS EUR 8.5 MLN VS LOSS OF
EUR 8.8
MLN YR AGO
    * H1 REVENUES EUR 1.7 MLN VS EUR 2.1 MLN YR AGO
    * H1 CURRENT OPERATING LOSS EUR 6.9 MLN VS LOSS OF EUR 5.5
MLN YR
AGO
    * CASH POSITION OF EUR 6.3 MILLION AT JUNE 30, 2019
COMPLEMENTED
BY NICE & GREEN EQUITY LINE, PROVIDING FINANCIAL VISIBILITY
UNTIL Q3 2020

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nBw29jKTFa
    
 Further company coverage:  ONXEO.SA  
   


 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920))

Recent news on Valerio Therapeutics SA

See all news